Efficacy of Phadiatop and skin prick test to detect inhalant allergen sensitization in children with frequent rhiniti
Not Applicable
- Conditions
- efficacy of Phadiatop
- Registration Number
- TCTR20190215002
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Children age 5-18 years old who had frequent rhinitis in the past year
**Definition: frequent rhinitis defined as rhinitis more than 6 times per year, and nasal symptoms (sneezing, itching, nasal obstruction, rhinorrhea) occur during two or more consecutive days for more than 1 h on most days
Exclusion Criteria
Children who had underlying chronic disease: liver disease, kidney disease, GI disease, autoimmune disease and uncontrolled asthma
Children who denied for the blood test
Children who could not perform skin prick test
Children do not consent for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of Phadiatop and skin prick test to detect inhalant allergen sensitization in children wi after enrollment diagnostic study
- Secondary Outcome Measures
Name Time Method none none none